Arthur K Melkonian
Overview
Explore the profile of Arthur K Melkonian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Melkonian A, Hakobyan G
Biotechnol Appl Biochem
. 2024 May;
71(5):1057-1069.
PMID: 38710664
Purpose of this article is to study the possible direct antiviral effect of "Armenikum" on SARS-CoV-2, conduct an in vitro study on the SARS-CoV-2 encephalomocarditis virus, and an in vivo...
2.
Brook R, Kleinman N, Choung R, Melkonian A, Smeeding J, Talley N
Clin Gastroenterol Hepatol
. 2010 Mar;
8(6):498-503.
PMID: 20304102
Background & Aims: Functional dyspepsia (FD) is a common morbid condition but data are limited on the direct and indirect costs for employees with FD or on its impact on...
3.
Lynch W, Markosyan K, Melkonian A, Pesa J, Kleinman N
Am J Manag Care
. 2009 Dec;
15(12):871-80.
PMID: 20001168
Objectives: To determine if antihypertensive medication adherence is associated with decreased medical and drug costs, medical service utilization, and work absence days. Study Design: Retrospective database study using medical, pharmacy,...
4.
Kleinman N, Brook R, Doan J, Melkonian A, Baran R
J Clin Psychiatry
. 2009 Sep;
70(8):1098-104.
PMID: 19758521
Objective: To objectively assess the economic impact of insomnia on direct medical and prescription costs and indirect absence-related salary replacement costs and on absences and to compare the prevalence and...
5.
Brook R, Rajagopalan K, Kleinman N, Melkonian A
Curr Med Res Opin
. 2009 May;
25(6):1469-76.
PMID: 19422277
Objective: The purpose of this analysis was to assess the differences in lost time and health-benefit costs (HBCs) among employees treated with disease modifying treatments (DMTs) for multiple sclerosis (MS)....
6.
Kleinman N, Brook R, Patel P, Melkonian A, Brizee T, Smeeding J, et al.
Value Health
. 2007 Jul;
10(4):231-7.
PMID: 17645677
Objective: The goal of this analysis was to evaluate the impact of gout, a painful inflammatory arthritis condition, on an employed population's health-related work absence and objectively measured productivity output....
7.
Novak S, Melkonian A, Patel P, Kleinman N, Joseph-Ridge N, Brook R
Curr Med Res Opin
. 2007 Mar;
23(3):623-30.
PMID: 17355743
Objective: A cohort of employees with gout were compared to those without to evaluate the differences in prevalence of disorders associated with metabolic syndrome (both those considered underlying and those...
8.
Brook R, Kleinman N, Patel P, Melkonian A, Brizee T, Smeeding J, et al.
Curr Med Res Opin
. 2006 Jul;
22(7):1381-9.
PMID: 16834837
Objective: To examine the economic burden of illness of gout in an employed population, quantifying the impact on employers annual health benefit costs for medical and prescription claims, sick leave,...
9.
Armenian H, Morikawa M, Melkonian A, Hovanesian A, Akiskal K, Akiskal H
J Urban Health
. 2002 Aug;
79(3):373-82.
PMID: 12200506
Most studies of psychopathology following disasters are concerned with posttraumatic stress disorder (PTSD). The present analyses sought to assess the rate and determinants of depression in adult survivors of the...